Skip to search formSkip to main contentSkip to account menu

saframycin Yd-1

Known as: Butanamide, 2-amino-N-((7-cyano-1,5,6,7,9,10,13,14,14a,15-decahydro-2,11-dimethoxy-3,12,16-trimethyl-1,4,10,13-tetraoxo-6,15-imino-4H-isoquino(3,2-b)(3)benzazocin-9-yl)methyl)-, saframycin-Yd1 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Isoquinolines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
1p-YD-1 強誘電性半導体ZnOの相転移 : X線的研究
1998
1998
31a-YD-1 K_3D(SO_4)_2での低温相での水素の秩序化パターン
1997
1997
6p-YD-1 非単調な入出力関係の学習曲線 : バッチモードでのRS解
1997
1997
29a-YD-1 表面チャネリングイオンのオコロコフ効果III
1996
1996
31a-YD-1 スピネル構造LiMn_2O_4のNMR(磁性(遷移金属合金・化合物))
1996
1996
3p-YD-1 IrMn反強磁性膜の交換結合特性(磁性(薄膜,人工格子))
1996
1996
2p-YD-1 反対称軌道酸素軌道を含むCuO_2面の有効ハミルトニアン(低温(高温超伝導・理論))
1995
1995
29p-YD-1 STM応用による圧電性薄膜の新計測法
1994
1994
4p-YD-1 ホウ素炭化物超伝導体LnM_2B_2C(Ln=Lu, Y, M=Ni, Pd)の圧力効果
1986
1986
Antitumor activity of new semisynthetic saframycin derivatives.
Saframycins Yd-1 and Y3, which have an amino functional group in the side chain, were recently obtained by a directed… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)